Coronary bare metal stent implantation in homozygous LDL receptor deficient swine induces a neointimal formation pattern similar to humans

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 518-524

  Tellez, Armando ^a   Krueger, Christian G ^b   Seifert, Paul ^c   Winsor Hines, Dawn ^c   Piedrahita, Cristian ^a   Cheng, Yanping ^a   Milewski, Krzysztof ^a   Aboodi, Michael S ^a   Yi, Genghua ^a   McGregor, Jennifer C ^a   Crenshaw, Tom ^b   Reed, Jess D ^b   Huibregtse, Barbara ^c   Kaluza, Greg L ^a   Granada, Juan F ^a  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Animal models of disease; Coronary neointimal formation; Familial hypercholesterolemic swine; Intravascular ultrasound; Optical coherence tomography

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ANGIOCARDIOGRAPHY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY STENT; FAMILIAL HYPERCHOLESTEROLEMIA; HISTOLOGY; INTIMA; INTRAVASCULAR ULTRASOUND; MALE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; SWINE;

ANIMALS; CORONARY RESTENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HYPERLIPOPROTEINEMIA TYPE II; MALE; RECEPTORS, LDL; STENTS; SWINE; TOMOGRAPHY, OPTICAL COHERENCE; TUNICA INTIMA;

EID: 78649726906     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.021     Document Type: Article

References (34)

1. Chorro F.J., Such-Belenguer L., Lopez-Merino V. Animal models of cardiovascular disease. Rev Esp Cardiol 2009, 62(1):69-84.
2. Lowe H.C., Schwartz R.S., Mac Neill B.D., et al. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc Interv 2003, 60(4):515-523.
3. Sahni D., Kaur G.D., Jit H., Jit I. Anatomy and distribution of coronary arteries in pig in comparison with man. Indian J Med Res 2008, 127(6):564-570.
4. Granada J.F., Kaluza G.L., Wilensky R.L., Biedermann B.C., Schwartz R.S., Falk E. Porcine models of coronary atherosclerosis and vulnerable plaque for imaging and interventional research. EuroIntervention 2009, 5(1):140-148.
5. Busnelli M., Froio A., Bacci M.L., et al. Pathogenetic role of hypercholesterolemia in a novel preclinical model of vascular injury in pigs. Atherosclerosis 2009, 207(2):384-390.
6. Gerrity R.G., Natarajan R., Nadler J.L., Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001, 50(7):1654-1665.
7. Hasler-Rapacz J., Ellegren H., Fridolfsson A.K., et al. Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet 1998, 76(5):379-386.
8. Prescott M.F., McBride C.H., Hasler-Rapacz J., Von Linden J., Rapacz J. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 1991, 139(1):139-147.
9. Mintz G.S., Nissen S.E., Anderson W.D., et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001, 37(5):1478-1492.
10. Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005, 112(2):270-278.
11. Balakrishnan B., Tzafriri A.R., Seifert P., Groothuis A., Rogers C., Edelman E.R. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation 2005, 111(22):2958-2965.
12. Drachman D.E. Drug-eluting stents in animals and patients: where do we stand today?. Circulation 2009, 120(2):101-103.
13. Carter A.J., Aggarwal M., Kopia G.A., et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004, 63(4):617-624.
14. Heldman A.W., Cheng L., Jenkins G.M., et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001, 103(18):2289-2295.
15. Wilson G.J., Polovick J.E., Huibregtse B.A., Poff B.C. Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model. Cardiovasc Res 2007, 76(2):361-372.
16. Virmani R., Kolodgie F.D., Farb A., Lafont A. Drug eluting stents: are human and animal studies comparable?. Heart 2003, 89(2):133-138.
17. Wilson G.J., Nakazawa G., Schwartz R.S., et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009, 120(2):141-149. 1-2.
18. Farb A., Sangiorgi G., Carter A.J., et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999, 99(1):44-52.
19. Farb A., Weber D.K., Kolodgie F.D., Burke A.P., Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002, 105(25):2974-2980.
20. Chieffo A., Foglieni C., Nodari R.L., et al. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. Am J Cardiol 2009, 104(12):1660-1667.
21. Kaneda H., Ako J., Terashima M., Waseda K., Yock P.G., Fitzgerald P.J. Distribution pattern of neointimal hyperplasia following sirolimus-eluting stent implantation assessed by 3-dimensional intravascular ultrasound. Int J Cardiol 2009, 135(2):243-245.
22. Rathore S., Kinoshita Y., Terashima M., Katoh O., Matsuo H., Tanaka N., Kimura M., Tsuchikane E., Nasu K., Ehara M., Asakura K., Asakura Y., Suzuki T. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents. EuroIntervention 2010, 5(7):841-846.
23. Russo R.J., Silva P.D., Yeager M. Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model. Heart 2007, 93(12):1609-1615.
24. Cilingiroglu M., Elliott J., Sangi P., et al. In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model. EuroIntervention 2009, 4(4):534-541.
25. Virmani R., Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol 1999, 10(6):499-506.
26. Grewe P.H., Deneke T., Machraoui A., Barmeyer J., Muller K.M. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000, 35(1):157-163.
27. Chung I.M., Gold H.K., Schwartz S.M., Ikari Y., Reidy M.A., Wight T.N. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 2002, 40(12):2072-2081.
28. Farb A., Kolodgie F.D., Hwang J.Y., et al. Extracellular matrix changes in stented human coronary arteries. Circulation 2004, 110(8):940-947.
29. Schwartz R.S., Edelman E.R., Carter A., et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 2002, 106(14):1867-1873.
30. Yutani C., Ishibashi-Ueda H., Suzuki T., Kojima A. Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis. Cardiology 1999, 92(3):171-177.
31. Paiva M.S., Serrano C.V., Nicolau J.C., et al. Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting. J Interv Cardiol 2008, 21(5):403-409.
32. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48(1):193-202.
33. Watanabe Y., Asano R., Hata N., et al. Late stent malapposition with marked positive vascular remodeling observed only at the site of drug-eluting stents after multivessel coronary stenting. Heart Vessels 2009, 24(4):308-312.
34. John M.C., Wessely R., Kastrati A., et al. Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents. JACC Cardiovasc Interv 2008, 1(5):535-544.